Cochlear® Nucleus® Nexa® System Named One of TIME’s Best Inventions of 2026
Cochlear® Nucleus® Nexa® System Named One of TIME's Best Inventions of 2026
World’s first and only smart cochlear implant system1,* recognized among TIME’s most groundbreaking innovations of the year
LONE TREE, Colo., Oct. 19, 2026 – Cochlear Limited (ASX: COH), a global leader in implantable hearing solutions, is excited to announce that the Cochlear® Nucleus® Nexa® System has been named one of TIME’s Best Inventions of 2026, recognizing its innovation in cochlear implant technology.
The Nucleus Nexa System was nominated by TIME’s editors for consideration for the 2026 list. To select this year’s Best Inventions, TIME solicited nominations from its editors and correspondents around the world, as well as direct applications process, with particular attention to growing fields such as health care and AI. TIME evaluated contenders based on key factors including originality, efficacy, ambition and impact.
“With the Nucleus Nexa System, we set out to create a cochlear implant platform designed not just for the technology of today, but for the possibilities of tomorrow,” said Dig Howitt, CEO and President, Cochlear.
"By bringing smart, upgradeable technology into the implant itself, the Nexa System opens up new possibilities for how cochlear implant technology can evolve over time. We’re incredibly proud to see that innovation recognized by TIME as one of the Best Inventions of 2026, and even more excited about what it can mean for recipients in the years ahead.”
Traditionally, innovation in cochlear implants has largely been delivered through the external sound processor, while the implanted component remained fixed after surgery. The Nucleus Nexa System changes that paradigm by introducing upgradeable firmware within the implant itself, enabling future innovation to be delivered through both the implant and sound processor.
For more information visit: Nucleus Nexa System | Smart cochlear implant system
About Cochlear Limited (ASX: COH)
People have always been Cochlear’s inspiration, ever since Professor Graeme Clark set out to create the first multi-channel cochlear implant after seeing his father struggle with hearing loss. Since 1981, Cochlear has helped more than 800,000 people of all ages in more than 180 countries to hear. As the global leader in implantable hearing solutions, Cochlear connects people with life’s opportunities, and welcomes them to the world’s largest hearing implant community.
Cochlear has a global workforce of more than 5,500 people with a passion for progress, who strive to meet the needs of people living with hearing loss. The company continually innovates to anticipate future needs, investing more than A$3 billion to date in research and development to push the boundaries of technology and help more people hear.
For more information please contact:
Christy LaPlante
E: pr-cochlearamericas@cochlear.com
*The only cochlear implant having onboard memory with upgradeable firmware. As future advancements or technology become available for the CI1000 series implant, a firmware update may be required in order to take advantage of newer features.
1Cochlear Limited. FUN5261. FDA Approval Letter for CI1000 Series Implant System. 2025
Disclaimer
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.
For a full list of Cochlear’s trademarks, please visit our Terms of Use page.